Larimar Therapeutics Inc
(LRMR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,009 | 49,331 | 40,777 | 32,352 | 35,595 |
| Marketable Securities | N/A | 68,735 | 61,275 | 96,842 | 149,484 |
| Receivables | N/A | 1,536 | 946 | 347 | 1,323 |
| TOTAL | $4,750 | $121,330 | $104,925 | $130,899 | $188,110 |
| Non-Current Assets | |||||
| PPE Net | 274 | 375 | 528 | 661 | 902 |
| Other Non-Current Assets | 177 | 57 | 57 | 61 | 94 |
| TOTAL | $451 | $432 | $585 | $722 | $996 |
| Total Assets | $5,201 | $121,762 | $105,510 | $131,621 | $189,106 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,539 | 3,590 | 3,020 | 2,572 | 7,495 |
| Accrued Expenses | 2,259 | 4,261 | 4,273 | 3,733 | 6,112 |
| TOTAL | $5,895 | $13,306 | $7,293 | $9,894 | $16,543 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 15,185 | 20,000 | N/A | 3,453 |
| TOTAL | $N/A | $15,185 | $20,000 | $N/A | $3,453 |
| Total Liabilities | $5,895 | $28,491 | $27,293 | $9,894 | $19,996 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,121 | 3,108 | 2,296 | 2,278 | 2,272 |
| Common Shares | 6 | 37 | 27 | 27 | 27 |
| Retained earnings | -23,132 | -350,945 | -289,577 | -237,549 | -179,671 |
| Other shareholders' equity | 0 | -33 | -58 | -80 | -207 |
| TOTAL | $-694 | $93,271 | $78,217 | $121,727 | $169,110 |
| Total Liabilities And Equity | $5,201 | $121,762 | $105,510 | $131,621 | $189,106 |